Pfizer scores six month extension for Lyrica patent

The FDA has handed a consolation prize to Pfizer, which is on the cusp of completely losing its patent on the company ’s best-selling drug, Lyrica.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news